{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T17:28:16Z","timestamp":1744651696141},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,27]]},"DOI":"10.7759\/cureus.23549","type":"journal-article","created":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T23:25:57Z","timestamp":1648423557000},"source":"Crossref","is-referenced-by-count":1,"title":["Post-vaccination Adverse Reactions After Receiving the Pfizer-BioNTech Coronavirus Disease 2019 Vaccines Among Healthcare Workers in Sapporo, Japan"],"prefix":"10.7759","author":[{"given":"Yoshinosuke","family":"Shimamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyasu","family":"Anbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Vaccination status for COVID-19. (2022). Accessed. February 27, 2022: https:\/\/cio.go.jp\/c19vaccine_dashboard."},{"key":"ref2","unstructured":"Information about the incidence of COVID-19. (2022). Accessed. February 27, 2022: https:\/\/www.mhlw.go.jp\/stf\/covid-19\/kokunainohasseijoukyou.html."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2112981","article-title":"Resurgence of SARS-CoV-2 infection in a highly vaccinated health system workforce","volume":"385","author":"Keehner J","year":"2021","unstructured":"Keehner J, Horton LE, Binkin NJ, et al.. Resurgence of SARS-CoV-2 infection in a highly vaccinated health system workforce. N Engl J Med. 2021, 385:1330-2. 10.1056\/NEJMc2112981","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2114228","article-title":"Waning immunity after the BNT162b2 Vaccine in Israel","volume":"385","author":"Goldberg Y","year":"2021","unstructured":"Goldberg Y, Mandel M, Bar-On YM, et al.. Waning immunity after the BNT162b2 Vaccine in Israel. N Engl J Med. 2021, 385:e85. 10.1056\/NEJMoa2114228","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2103916","article-title":"Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19","volume":"384","author":"Doria-Rose N","year":"2021","unstructured":"Doria-Rose N, Suthar MS, Makowski M, et al.. Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19. N Engl J Med. 2021, 384:2259-61. 10.1056\/NEJMc2103916","journal-title":"N Engl J Med"},{"key":"ref6","unstructured":"Notice about additional vaccination for COVID-19. (2022). Accessed. February 27, 2022: https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/vaccine_booster.html."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2114255","article-title":"Protection of BNT162b2 vaccine booster against Covid-19 in Israel","volume":"385","author":"Bar-On YM","year":"2021","unstructured":"Bar-On YM, Goldberg Y, Mandel M, et al.. Protection of BNT162b2 vaccine booster against Covid-19 in Israel. N Engl J Med. 2021, 385:1393-400. 10.1056\/NEJMoa2114255","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02249-2","article-title":"Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study","volume":"398","author":"Barda N","year":"2021","unstructured":"Barda N, Dagan N, Cohen C, et al.. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet. 2021, 398:2093-100. 10.1016\/S0140-6736(21)02249-2","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2115926","article-title":"Protection against Covid-19 by BNT162b2 booster across age groups","volume":"385","author":"Bar-On YM","year":"2021","unstructured":"Bar-On YM, Goldberg Y, Mandel M, et al.. Protection against Covid-19 by BNT162b2 booster across age groups. N Engl J Med. 2021, 385:2421-30. 10.1056\/NEJMoa2115926","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2115624","article-title":"BNT162b2 vaccine booster and mortality due to Covid-19","volume":"385","author":"Arbel R","year":"2021","unstructured":"Arbel R, Hammerman A, Sergienko R, Friger M, Peretz A, Netzer D, Yaron S. BNT162b2 vaccine booster and mortality due to Covid-19. N Engl J Med. 2021, 385:2413-20. 10.1056\/NEJMoa2115624","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01527-y","article-title":"Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis","volume":"27","author":"Choi A","year":"2021","unstructured":"Choi A, Koch M, Wu K, et al.. Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis. Nat Med. 2021, 27:2025-31. 10.1038\/s41591-021-01527-y","journal-title":"Nat Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7039e4","article-title":"Safety monitoring of an additional dose of COVID-19 vaccine - United States, August 12-September 19, 2021","volume":"70","author":"Hause AM","year":"2021","unstructured":"Hause AM, Baggs J, Gee J, Marquez P, Myers TR, Shimabukuro TT, Shay DK. Safety monitoring of an additional dose of COVID-19 vaccine - United States, August 12-September 19, 2021. MMWR Morb Mortal Wkly Rep. 2021, 70:1379-84. 10.15585\/mmwr.mm7039e4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.31662\/jmaj.2021-0103","article-title":"Local and systemic reaction after receiving coronavirus disease vaccines among healthcare workers in Sapporo, Japan","volume":"4","author":"Shimamura Y","year":"2021","unstructured":"Shimamura Y, Anbo Y, Furuta Y. Local and systemic reaction after receiving coronavirus disease vaccines among healthcare workers in Sapporo, Japan. JMA J. 2021, 4:420-2. 10.31662\/jmaj.2021-0103","journal-title":"JMA J"},{"key":"ref14","unstructured":"Toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials. (2022). Accessed. March 17, 2021:  https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/toxicity-grading-scale-healthy-adult-and-ad...."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"R\u00fcggeberg JU","year":"2007","unstructured":"R\u00fcggeberg JU, Gold MS, Bayas JM, et al.. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2007, 25:5675-84. 10.1016\/j.vaccine.2007.02.064","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116597","article-title":"Effect of Covid-19 vaccination on transmission of alpha and delta variants","volume":"386","author":"Eyre DW","year":"2022","unstructured":"Eyre DW, Taylor D, Purver M, et al.. Effect of Covid-19 vaccination on transmission of alpha and delta variants. N Engl J Med. 2022, 386:744-56. 10.1056\/NEJMoa2116597","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/90598-post-vaccination-adverse-reactions-after-receiving-the-pfizer-biontech-coronavirus-disease-2019-vaccines-among-healthcare-workers-in-sapporo-japan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:28Z","timestamp":1707507748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/90598-post-vaccination-adverse-reactions-after-receiving-the-pfizer-biontech-coronavirus-disease-2019-vaccines-among-healthcare-workers-in-sapporo-japan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,27]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.23549","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,27]]}}}